Form 8-K

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported)  

June 17, 2003

 

 

Targeted Genetics Corporation

(Exact name of registrant as specified in charter)

 

 

Washington   0-23930   91-1549568

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

1100 Olive Way, Suite 100, Seattle, Washington   98101
(Address of principal executive offices)   (Zip Code)

 

 

Registrant’s telephone number, including area code  

(206) 623-7612

 

 

Not Applicable

(Former name or former address, if changed since last report)

Item 5.    Other Events.

 

On June 17, 2003, Targeted Genetics Corporation announced that it completed a public offering of approximately 7.8 million shares of its common stock at a price of $2.25 per share to institutional investors, for gross proceeds of approximately $17.5 million. The text of the press release is set forth in Exhibit 99.1 attached to this release and incorporated herein by this reference.

 

Item 7.    Exhibits.

 

  (a) Financial statements of business acquired.

 

Not applicable.

 

  (b) Pro forma financial information.

 

Not applicable.

 

  (c) Exhibits.

 

Exhibit No.
   

Description

99.1   

Press Release dated June 17, 2003

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

TARGETED GENETICS CORPORATION

Date:    June 17, 2003       By:  

/s/    TODD E. SIMPSON

           

Todd E. Simpson

Vice President, Finance and Administration and Chief Financial Officer, Secretary and Treasurer

(Principal Financial and Accounting Officer)

EXHIBIT INDEX

 

Exhibit No.
   

Description

99.1   

Press Release dated June 17, 2003